2 IPOs Planned for the Week of February 24

Francis Gaskins  |

The full IPO calendar is available at IPOpremium.com.

Lumenis

(1) Based in Yokneam, Israel, Lumenis ($LMNS) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $564 million at a price range midpoint of $16 for Thursday, February 27, 2014.

LMNS provides energy-based, minimally invasive clinical solutions primarily for the aging population.

LMNS established a strong brand across diverse end-markets, consisting of its surgical, ophthalmic and aesthetic segments.

Varonis Systems

(2) Based in New York, NY, Varonis Systems ($VRNS) scheduled a $86.4 million IPO on the Nasdaq with a market capitalization of $429 million at a price range midpoint of $18 for February, Friday 28, 2014.

VRNS provides specialized enterprise software.  2013 revenue grew 40% to $75 million from $53 million, gross margin remained constant at 91%, and losses increased 54% to -$7.5 million from -$4.8 million.

42% of revenue is recurring from maintenance and services.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Companies

Symbol Name Price Change % Volume
VRNS Varonis Systems Inc. 85.26 -1.89 -2.17 325,795 Trade
RHWI Riverhawk Aviation Inc 0.02 0.00 0.00 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG

     

Blockchain in Healthcare - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Digital Health - How Blockchain technology can make health care systems more patient-centric and sustainable